Bench to Bedside: Lifitegrast, pt.2 - Discovery and development of Lifitegrast - Tom Gadek

(33:30)

lifitegrast mechanism and role of icam 1

(2:32)

Dry Eye Disease MoA Animation

(2:49)

What is Lifitegrast? | Lifitegrast for Dry Eye Syndrome Treatment | Xiidra versus Restasis

(5:1econd)

Bench to Bedside: Lifitegrast, pt.1 - The SARcode Story: How to build a biotech company - Tom Gadek

(49:52)

Xiidra (lifitegrast ophthalmic solution) how to use: Mechanism of action, Uses, Dosage, Side Effects

(2:31)

Bench to Bedside: Lifitegrast, pt.3 - Clinical study - Tom Gadek

(38:49)

Xiidra Vs Restasis: Which is better?

(11:36)

Updates and Best Practices: Intense Pulsed Light (IPL) Therapy for Dry Eye

(49:19)

iFocus Online Session 55 - Blepharitis and Meibomian Gland Dysfunction by Dr Akanksha Koul

(59:4)

Best DRY EYE TREATMENTS for 2024! What Works?

(6:15)

Lecture: Dry Eye: Evolving Diagnostics and Care

(57:40)

The Multifactorial Approach to Dry Eye Disease

(53:16)

AIOCMT3 2024 - GP67 - Dry Eye

(1:15:5)

Myositis and overlapping autoimmune diseases, Dr Rossitza Chichkova

(1:7:49)

Conquering Dry Eye with Cutting Edge Tech and Treatments

(40:45)

Tirzepatide's Unique Mechanism of Action - GIP/GLP-1 Dual Agonist

(8:24)

Industry Spotlight: Regener-Eyes

(16:33)

Xiidra (5% lifitegrast ophthalmic solution) - Drug Rx Information

(4:53)

Targeting Dry Eye Inflammation: Is There a Clear Choice?

(2:35)

Lifitegrast in Dry Eye Patients Undergoing Cataract Surgery - Video abstract [ID 264520]

(2:24)

Let’s Talk Early Treatment With Xiidra® (lifitegrast ophthalmic solution) 5%

(2:17)

Tech Talk: Become a De-TECH-tive | Xiidra® (lifitegrast ophthalmic solution) 5%

(9:15)

Hot Topics - What pharmaceutical products beat dry eye disease?

(1:34)

Lifitegrast (Your EYEBALLS) 👁️👁️💉😳💊🔊💯✅

(1:36)

What are the side effects of Xiidra Lifitegrast Ophthalmic

(1:5)

AIOC 2023 IC525 topic DR NAMRATA SHARMA Lifitegrast ophthalmic solution 5% a review in dry eye

(6:53)

How Fluid Circulates in the Eye

(1:6)

What is Xiidra? | #SHORTS

(58)

Gain Insights Into Factors That May Motivate Dry Eye Patients to Remain on Their Treatment

(2:28)